Mastercard Incorporated vs Novartis AG
Mastercard Incorporated is worth $524.266B, 1.8× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $524.266B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $598.47 | $157.54 |
| Change | +6.60% | +1.90% |
| Revenue | $32.791B | $56.674B |
| Net income | $14.968B | $13.984B |
| Country | United States | Switzerland |
| Sector | Financial Services | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is Mastercard Incorporated bigger than Novartis AG?
- Mastercard Incorporated has a market cap of $524.266B against $299.439B for Novartis AG, making it 1.8 times as valuable.
- Which company earns more, MA or NVS?
- Mastercard Incorporated reported net income of $14.968B and Novartis AG reported $13.984B in their most recent annual periods.